The Biomarkers in Depression Study (BIODEP) is the Consortium’s first clinical study, involving volunteers both with and without depression. The study is a collaboration between 5 UK universities and 4 pharmaceutical companies. The aim of the study is to find biomarkers for depression.
Biomarkers (Biological Markers) are “A naturally occurring molecule, gene, or characteristic by which a particular pathological or physiological process, disease, etc. can be identified.” For example, body temperature is a well-known biomarker for fever.
We have a number of articles in the process of being published based on the data we have collected.
Below are the currently published Biodep articles: